Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets

被引:33
作者
Crist, SA
Elzey, BD
Ludwig, AT
Griffith, TS
Staack, JB
Lentz, SR
Ratliff, TL
机构
[1] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[2] Univ Iowa, Prostate Canc Res Grp, Iowa City, IA 52242 USA
[3] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA
[4] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[5] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA
[6] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1016/j.exphem.2004.07.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Platelets are known to play an important role in hemostasis, thrombosis, wound healing, and inflammation. Platelet-induced modulation of inflammation and adaptive immune responses are mediated in part through tumor necrosis factor (TNF) family member ligands, including CD154, Fas ligand, and TNFalpha, that are expressed upon platelet activation. The present study investigated whether platelets and megakaryocytes also express TNF-related apoptosis-inducing ligand (TRAIL), another pro-apoptotic member of the TNF superfamily. Materials and Methods. Immunoprecipitation, enzyme-linked immunosorbent assay, and flow cytometry were used to assess TRAIL protein expression on isolated platelets, in vitro-derived megakaryocytes and premegakaryocyte cell lines. Reverse-transcription polymerase chain reaction and transient transfection of TRAIL promoter/reporter constructs were used to elucidate mechanisms of TRAIL regulation during megakaryocyte differentiation. TRAIL-dependent cytotoxicity assays were performed to determine if platelet-derived TRAIL induces apoptosis of TRAIL sensitive target cells. Results. Activated platelets expressed both membrane-bound and soluble TRAIL. TRAIL was also expressed by megakaryocytes, and in vitro studies showed that TRAIL expression was induced upon megakaryocyte differentiation. TRAIL expression was mediated by increased transcriptional activity of the TRAIL promoter, suggesting lineage-specific regulation of TRAIL during megakaryocyte differentiation. Abundant detergent-extractable, full-length TRAIL protein was observed in the lysates of platelets and megakaryocytes, but only low concentrations of TRAIL were released by nondetergent extraction methods. Conclusion. The data reported herein show that platelets express TRAIL that is synthesized by megakaryocytes and was expressed by activated platelets. While these data expand the spectrum of TNF family proteins expressed in platelets, the function of platelet-derived TRAIL is not known. (C) 2004 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:1073 / 1081
页数:9
相关论文
共 54 条
[31]   Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure [J].
Perianayagam, MC ;
Murray, SL ;
Balakrishnan, VS ;
Guo, DQ ;
King, AJ ;
Pereira, BJG ;
Jaber, BL .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (04) :320-327
[32]   Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor [J].
Renshaw, SA ;
Timmons, SJ ;
Eaton, V ;
Usher, LR ;
Akil, M ;
Bingle, CD ;
Whyte, MKB .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (05) :662-668
[33]   Acceleration of human neutrophil apoptosis by TRAIL [J].
Renshaw, SA ;
Parmar, JS ;
Singleton, V ;
Rowe, SJ ;
Dockrell, DH ;
Dower, SK ;
Bingle, CD ;
Chilvers, ER ;
Whyte, MKB .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :1027-1033
[34]   Evidence for platelet αIIbβ3 activation despite elevated cytosolic cAMP [J].
Riondino, S ;
Gazzaniga, PP ;
Pulcinelli, FM .
THROMBOSIS AND HAEMOSTASIS, 2001, 85 (02) :320-325
[35]  
Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO
[36]  
2-B
[37]   IFN-γ induces cell death in human hepatoma cells through a trail/death receptor-mediated apoptotic pathway [J].
Shin, EC ;
Ahn, JM ;
Kim, CH ;
Choi, Y ;
Ahn, YS ;
Kim, H ;
Kim, SJ ;
Park, JH .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (02) :262-268
[38]  
Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO
[39]  
2-C
[40]  
Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008